News headlines about Balchem (NASDAQ:BCPC) have been trending somewhat positive recently, according to Accern Sentiment. The research group rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Balchem earned a news sentiment score of 0.23 on Accern’s scale. Accern also assigned news stories about the basic materials company an impact score of 46.3239802129508 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Shares of Balchem (BCPC) opened at $82.37 on Wednesday. Balchem has a 52 week low of $70.23 and a 52 week high of $88.47. The firm has a market cap of $2,638.84, a price-to-earnings ratio of 29.52 and a beta of 1.05. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.28 and a current ratio of 1.84.
Balchem (NASDAQ:BCPC) last announced its quarterly earnings data on Tuesday, February 27th. The basic materials company reported $0.68 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.06. Balchem had a net margin of 15.14% and a return on equity of 14.16%. The firm had revenue of $159.26 million during the quarter.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by BBNS and is owned by of BBNS. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this news story can be viewed at https://baseballnewssource.com/2018/03/14/balchem-bcpc-receiving-somewhat-positive-media-coverage-analysis-finds/1971062.html.
Balchem Company Profile
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.